These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 3539013
1. In vitro activity of DQ-2556, a new cephalosporin. Fujimoto T, Otani T, Nakajima R, Une T, Osada Y. Antimicrob Agents Chemother; 1986 Oct; 30(4):611-3. PubMed ID: 3539013 [Abstract] [Full Text] [Related]
2. Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin. Fuchs PC, Jones RN, Barry AL, Thornsberry C. Antimicrob Agents Chemother; 1985 May; 27(5):679-82. PubMed ID: 3893316 [Abstract] [Full Text] [Related]
3. An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa. van Klingeren B. J Antimicrob Chemother; 1981 Sep; 8 Suppl B():97-105. PubMed ID: 19810171 [Abstract] [Full Text] [Related]
5. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime. Masuyoshi S, Hiraoka M, Inoue M, Tomatsu K, Hirano M, Mitsuhashi S. Drugs Exp Clin Res; 1989 Sep; 15(1):1-10. PubMed ID: 2663406 [Abstract] [Full Text] [Related]
6. [In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime]. Le Noc P, Bryskier A, Le Noc D. Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):567-71. PubMed ID: 3534744 [Abstract] [Full Text] [Related]
7. In vitro and in vivo activity of DQ-2556, a new cephalosporin. Ishida Y, Miyazaki S, Yamaguchi K, Goto S. Chemotherapy; 1995 Jun; 41(1):5-13. PubMed ID: 7875022 [Abstract] [Full Text] [Related]
9. In vitro antibacterial activity and beta-lactamase stability of CL 118523, an aminothiazolyl iminomethoxy cephalosporin. Chin NX, Neu HC. Chemioterapia; 1987 Oct; 6(5):329-36. PubMed ID: 3322588 [Abstract] [Full Text] [Related]
10. GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae. Verbist L, Verhaegen J. Antimicrob Agents Chemother; 1980 May; 17(5):807-12. PubMed ID: 6994640 [Abstract] [Full Text] [Related]
11. Antibacterial properties of Ro 13-99041, a long-acting new cephalosporin. Angehrn P, Probst PJ. Chemotherapy; 1981 May; 27 Suppl 1():9-14. PubMed ID: 7249797 [Abstract] [Full Text] [Related]
15. In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents. Beskid G, Fallat V, Lipschitz ER, McGarry DH, Cleeland R, Chan K, Keith DD, Unowsky J. Antimicrob Agents Chemother; 1989 Jul; 33(7):1072-7. PubMed ID: 2782857 [Abstract] [Full Text] [Related]
16. In vitro and in vivo activities of DN-9550, a new broad-spectrum cephalosporin. Une T, Otani T, Sato M, Ikeuchi T, Osada Y, Ogawa H, Sato K, Mitsuhashi S. Antimicrob Agents Chemother; 1985 Apr; 27(4):473-8. PubMed ID: 3873898 [Abstract] [Full Text] [Related]
20. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics. Phillips I, Warren C, Shannon K, King A, Hanslo D. J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967 [Abstract] [Full Text] [Related] Page: [Next] [New Search]